Cargando…
Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination
Autores principales: | Tomayko, Mary M., Damsky, William, Fathy, Ramie, McMahon, Devon E., Turner, Noel, Valentin, Monica N., Rallis, Tena, Aivaz, Ohara, Fox, Lindy P., Freeman, Esther E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280592/ https://www.ncbi.nlm.nih.gov/pubmed/34275656 http://dx.doi.org/10.1016/j.jaci.2021.06.026 |
Ejemplares similares
-
Development of bullous pemphigoid during nivolumab therapy
por: Damsky, William, et al.
Publicado: (2016) -
Detection of Anti-basement Membrane Zone Antibodies in the Blister Fluid in Subepidermal Autoimmune Bullous Diseases
por: Surya, Ravindran, et al.
Publicado: (2017) -
Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases
por: Zebrowska, Agnieszka, et al.
Publicado: (2015) -
Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid
por: Leighty, Lisa, et al.
Publicado: (2007) -
Commentary: Proinflammatory role of blister fluid-derived exosomes in bullous pemphigoid
por: Liu, Yangchun, et al.
Publicado: (2020)